Brazil's Bolsonaro accepts no proof chloroquine works, but may work in some cases

Brazil President Jair Bolsonaro, a long-running advocate of malaria drug chloroquine to treat COVID-19, said on Thursday he knew there was no proof it works, but said there are cases in which it appears to have been successful.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news

Related Links:

Researchers say that a malaria drug President Donald Trump took to try to prevent COVID-19 proved ineffective for that in the first large, high-quality study to test it in health workers and others closely exposed to people with the disease
Source: ABC News: Health - Category: Consumer Health News Tags: Health Source Type: news
U.S. President Donald Trump had no side effects from a two-week course of hydroxychloroquine, an anti-malaria drug that can cause heart problems, after using it as a preventive measure against the coronavirus, his White House physician said on Wednesday.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
The malaria drug promoted by U.S. President Donald Trump as a treatment for COVID-19 was shown to be ineffective in preventing infection in people exposed to the coronavirus, according to a widely anticipated clinical trial released on Wednesday.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
Eunice G. Kamwendo is an Economist and Strategic Advisor with UNDP Africa in New York. Chaltu Daniel Kalbessa is a UNDP Fellow and Strategic Analyst with UNDP Africa in New York.By Eunice G. Kamwendo and Chaltu Daniel KalbessaNEW YORK, Jun 3 2020 (IPS) With very weak health systems and overall capacity constraints to effectively respond to the deadly coronavirus disease, Africa’s fate against the invisible enemy, was going to be nothing short of catastrophic according to early predictions. Although Africa is yet to reach its peak, many countries are not seeing the exponential growth in case numbers, or in mortality r...
Source: IPS Inter Press Service - Health - Category: International Medicine & Public Health Authors: Tags: Africa Aid Headlines Health Humanitarian Emergencies TerraViva United Nations Source Type: news
(Natural News) If you only listened to the mainstream media, you might think hydroxychloroquine is a risky medication that does nothing to help COVID-19 patients, but the truth is that it’s a drug that has been used for 65 years to prevent and treat illnesses like lupus, malaria and rheumatoid arthritis and has been officially...
Source: NaturalNews.com - Category: Consumer Health News Source Type: news
British medical journal the Lancet on Tuesday said it had concerns about data behind an influential article that found hydroxychloroquine increased the risk of death in COVID-19 patients, a conclusion that undercut scientific interest in the medicine championed by U.S. President Donald Trump.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
Concerns are mounting about studies in two influential medical journals on drugs used in people with coronavirus, including one that led multiple countries to stop testing a malaria pill
Source: ABC News: Health - Category: Consumer Health News Tags: Health Source Type: news
Sanofi has temporarily stopped recruiting new COVID-19 patients for two clinical trials on hydroxychloroquine and will no longer supply the anti-malaria drug to treat COVID-19 until concerns about safety are cleared up, it said on Friday.Reuters Health Information
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Infectious Diseases News Source Type: news
US hospitals said they have pulled way back on the use of hydroxychloroquine, the malaria drug touted by President Donald Trump as a COVID-19 treatment, after several studies suggested it is not effective and may pose significant risks.Reuters Health Information
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Infectious Diseases News Source Type: news
[Ghanaian Times] Wa -The AGA Mal-AngloGold Malaria Control Programme has provided a US$300,000 support package to the Upper West Region to help in the management of the Coronavirus (CODVID-19) pandemic.
Source: AllAfrica News: Malaria - Category: Infectious Diseases Source Type: news
More News: Brazil Health | COVID-19 | Health | Malaria